ArticlePDF AvailableLiterature Review

Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas and Lymphangiomas

Authors:

Abstract and Figures

Cystic hygroma is a type of lymphangioma, which is a vascular anomaly associated with lymphatic malformations and formed by fluid accumulation mainly located at the cervicofacial and axillary regions. Cystic hygroma is mostly located in the neck (75%), followed by axilla (20%), retroperitoneum and intra-abdominal organs (2%), limbs and bones (2%), and mediastinum (1%). It is often associated with chromosome aneuploidies, hydrops fetalis, and even intrauterine fetal demise. The prognostic factors of the fetal cystic hygroma or lymphangioma are chromosome abnormalities, hydrops fetalis, septations, or thickness of the cystic hygroma and are associated with other major malformations. Prenatal managements including ultrasound serial follow-up, magnetic resonance imaging, or even intrauterine injection of sclerosing agents are suggested. For fetus with the risk of airway obstruction at delivery, ex utero intrapartum treatment is also indicated. Detailed prenatal counseling is necessary for better neonatal outcome.
Content may be subject to copyright.
REVIEW ARTICLE
Prenatal Ultrasound Evaluation and Outcome
of Pregnancy with Fetal Cystic Hygromas and
Lymphangiomas
Yen-Ni Chen
1
, Chih-Ping Chen
1,2,3,4,5,6
*, Chen-Ju Lin
1
,
Shin-Wen Chen
1
1
Department of Obstetrics and Gynecology,
2
Department of Medical Research, Mackay Memorial
Hospital, Taipei, Taiwan,
3
Institute of Clinical and Community Health Nursing,
4
Department of
Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan,
5
Department of Biotechnology, Asia University, and
6
School of Chinese Medicine, College of Chinese
Medicine, China Medical University, Taichung, Taiwan
Received 17 January 2017; accepted 21 February 2017
Available online ---
KEYWORDS
cystic hygroma,
hydrops fetalis,
lymphangioma,
nuchal translucency
Abstract Cystic hygroma is a type of lymphangioma, which is a vascular anomaly associated
with lymphatic malformations and formed by fluid accumulation mainly located at the cervi-
cofacial and axillary regions. Cystic hygroma is mostly located in the neck (75%), followed
by axilla (20%), retroperitoneum and intra-abdominal organs (2%), limbs and bones (2%), and
mediastinum (1%). It is often associated with chromosome aneuploidies, hydrops fetalis, and
even intrauterine fetal demise. The prognostic factors of the fetal cystic hygroma or lymphan-
gioma are chromosome abnormalities, hydrops fetalis, septations, or thickness of the cystic
hygroma and are associated with other major malformations. Prenatal managements including
ultrasound serial follow-up, magnetic resonance imaging, or even intrauterine injection of
sclerosing agents are suggested. For fetus with the risk of airway obstruction at delivery, ex
utero intrapartum treatment is also indicated. Detailed prenatal counseling is necessary for
better neonatal outcome.
ª2017, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Conflicts of interest: The authors have no conflicts of interest relevant to this article.
* Correspondence to: Dr Chih-Ping Chen, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan
North Road, Taipei, Taiwan.
E-mail address: cpc_mmh@yahoo.com (C.-P. Chen).
+MODEL
Please cite this article in press as: Chen Y-N, et al., Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas
and Lymphangiomas, Journal of Medical Ultrasound (2017), http://dx.doi.org/10.1016/j.jmu.2017.02.001
http://dx.doi.org/10.1016/j.jmu.2017.02.001
0929-6441/ª2017, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Chinese Taipei Society o
f
Ultrasound in Medicine
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.jmu-online.com
Journal of Medical Ultrasound (2017) xx,1e4
Introduction
There are different nomenclatures of cystic hygroma.
Cystic hygroma is a type of lymphangioma, which is also
called nuchal edema or increased nuchal translucency (NT)
during the first trimester. It is a vascular anomaly associ-
ated with lymphatic malformations and formed by fluid
accumulation mainly located at the cervicofacial and axil-
lary regions [1]. It is mainly located in the neck (75%),
followed by axilla (20%), retroperitoneum and intra-
abdominal organs (2%), limbs and bones (2%), and medias-
tinum (1%) [2,3]. The thickness is usually S3 mm. The
incidence of nuchal cystic hygroma is about 1/6000 at birth
and about 1/750 in spontaneous abortion [4].
It is not only associated with lymphatic malformation
but also with chromosome aneuploidies, hydrops fetalis,
and even intrauterine fetal demise (IUFD). The prognosis is
often considered poor. However, cystic hygroma could be
transient in ultrasound findings. It might regress during
pregnancy because of recanalization or the formation of
collaterals [5].
Here, we will review the diagnosis, factors that affect
the prognosis, and the possible management of fetal cystic
hygroma for better perinatal outcome.
Prenatal ultrasound findings
Ultrasound findings of cystic hygroma include thin-walled
and serpiginous or multiseptated intradermal fluid collec-
tions which are often found at cervical regions [6]. Ville
et al [7] defined nuchal cystic hygroma as an area of
sonolucency in the soft tissue of the occipital region, con-
sisted of two symmetrical cavities completed separated by
a midline septum, with or without the internal trabeculae
(multiloculated cysts). NT is the presence of unilocular
collection of nuchal fluid S3mm
3
. The thickness of the
cystic hygroma is measured at its widest part from the
intact skull or skin at the transverse view. Prenatal ultra-
sound of cystic hygroma may show increased nuchal thick-
ness (S3mm), with or without septation at the neck region
or thin-walled, sonolucent, and multilocular structure at
other regions (Figures 1 and 2). Color Doppler may show no
obvious internal flow which can be distinguished from
hemangioma (Figure 3). Besides, the color Doppler ultra-
sound is also effective for the detection of intralesional
hemorrhage. It may show pulsations from the septums to-
ward the cysts [8]. Furthermore, differential diagnosis
should also include encephalocle or cervical teratoma.
Head and spine morphologies should be further evaluated
for suspected neural tubal defects. Polyhydramnios is also
an indicator of neural tube defect but seldom seen in cystic
hygroma.
Cystic hygroma in the anterior triangle of the neck is
often associated with airway compression, which needs
more aggressive intrapartum management. Further image
evaluation using MRI is also recommended prior to birth for
definite tumor size and infiltration pattern.
Common associated ultrasound findings are hydrops
fetalis, cardiac malformations, and skeletal abnormal-
ities. Cardiac malformations are the main anomalies
detected in fetuses with normal karyotype (62.2e72.7%)
[9]. Other major malformations, such as hydrocephalus,
arthrogryposis, agenesis of corpus callosum, pes equi-
novarus, diaphragmatic hernia, amniotic band syndrome,
mesomelia, and bilateral hydronephrosis, were also re-
ported in patients with septated cystic hygroma and
normal karyotype [10].
Figure 1 Neck cystic hygroma with a thickness of 13.9 mm.
Figure 2 Lymphangioma over the abdominal area (arrow).
Figure 3 Color Doppler ultrasounds of cystic hygroma
showed no internal flow.
2 Y.-N. Chen et al.
+MODEL
Please cite this article in press as: Chen Y-N, et al., Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas
and Lymphangiomas, Journal of Medical Ultrasound (2017), http://dx.doi.org/10.1016/j.jmu.2017.02.001
Outcome
Cystic hygroma is well known with poor outcome because
the fetuses usually have chromosomal abnormalities and
hydrops fetalis or IUFD often occurs during pregnancy. The
unfavorable outcome is 77.8%. However, there are also
patients with cystic hygroma with resolution or survive at
birth without other malformations (16.7e22.2%) [9,11].
There are several factors that can affect and predict the
outcome of cystic hygroma (Table 1).
About 50% of fetal cystic hygromas are found with
chromosomal abnormalities [9,11e13]. The most common
chromosome abnormalities associated with cystic hygroma
are Trisomy 21 and Turner syndrome. Other abnormalities,
such as Trisomy 18, Trisomy 13, and Triploidy, were also
reported. Beside aneuploidies, recent studies showed that
some copy number variants (CNVs) were also associated
with cystic hygroma or increased NT, and it can be detected
by using microarray [14,15]. A meta-analysis showed that
the most common pathologic CNVs are 22q11.2 micro-
deletion syndrome and then 22q11.2 duplication. Others
are 10q26.12q26.3 deletion, 12q21q22 deletion, 1p36
deletion, and Sotos syndrome. Genomic microarray pro-
vides a 5.0% incremental yield of detecting CNVs in fetuses
with increased NT and normal karyotype [14]. Noonan
syndrome is also frequently noted in fetuses with cystic
hygroma. Other genetic disorders, such as Roberts syn-
drome, Cornelia de Lange syndrome, and multiple pteryg-
ium syndrome, are rare; however, they were also reported
in the first-trimester cystic hygroma, and 4p deletion and
unbalanced chromosome 10 were reported at second-
trimester cystic hygroma [9,16] (Table 2).
Although cystic hygroma might be resolved during
pregnancy, whether it would be resolved or not is not
related to the fetal karyotype. However, when it progresses
to hydrops fetalis, the prognosis is not favorable. Several
studies showed that the thickness was also associated with
the prognosis. Tanriverdi et al [12] showed that fetuses
with normal karyotype and nuchal size >6.5 mm had worse
prognosis. Graesslin et al [11] also showed that fetuses with
cystic hygroma <6 mm had good prognosis but not
including those with hydrops fetalis. Scholl et al [17]
showed that the increased thickness of NT is associated
with the increase of the odds of abnormal karyotype, major
congenital anomaly, perinatal loss, and other poor
outcomes.
Rosati and Guariglia [5] reported that 63.2% of non-
septated cystic hygromas and 28.6% of septated cystic
hygromas regressed spontaneously in utero. Compared with
nonseptated cystic hygromas, septated cystic hygromas
have more risk of aneuploidy and worse prognosis, such as
hydrops fetalis [5,16,18]. Turner syndrome was found in
septated hygromas only (30/39), and Trisomy 21 was the
most commonly found abnormal karyotype in nonseptated
hygromas (5/16). Hydrops fetalis was more common in
septated cystic hygromas than in nonseptated cystic
hygromas (60% vs. 19%). Besides, the survival rates were
higher in nonseptated cystic hygromas (27%) than in sep-
tated cystic hygromas (2%).
Nuchal lymphangiomas are likely to be associated with
chromosomal abnormalities. However, when the mass is
located at axilla, the relationship between lymphangioma
and aneuploidies is slightly lower than nuchal lym-
phangioma [8]. It is uncertain that non-nuchal lym-
phangiomas have same risk of chromosome abnormalities
because of the paucity of available data. Lymphangiomas at
the anterior neck have the possibility of airway compres-
sion, which needs airway protection and neonatal resusci-
tative service intrapartum. For those fetuses with
lymphangioma at the trunk region, dystocia and hemor-
rhage secondary to trauma should be alerted and cesarean
section delivery is indicated [19]. Mondal et al [20] reported
a case of congenital fetal lymphangioma causing shoulder
dystocia and uterine rupture without prenatal diagnosis.
IUFD was also noted at laparotomy.
Management
For the management of fetal cystic hygroma or lym-
phangioma, the first common step is cytogenetic study for
suspected aneuploidy, and array comparative genomic hy-
bridization is also recommended for other genetic disor-
ders. Detailed and serial ultrasound examination for follow-
up of the growth of the tumor is necessary. These results
are important for prenatal counseling. For patients with
normal karyotype and favorable prognosis, further consul-
tation with a pediatric surgeon was also needed for post-
natal management. Because huge cystic hygroma may
cause dystocia, neonatal airway compression, or feeding
Table 1 Poor prognostic factors of cystic hygromas and
lymphangiomas.
Chromosome abnormalities
Hydrops fetalis
Thickness of cystic hygroma S6mm
Septated cystic hygromas
Nuchal cystic hygroma
Associated with other major malformations
Table 2 Aneuploidies and genetic disorders associated
with cystic hygromas and lymphangiomas.
Aneuploidies
Trisomy 21
Turner syndrome
Trisomy 18
Trisomy 13
Triploidy
Copy number variants
22q11.2 deletion
22q11.2 duplication
10q26.12q26.3 deletion
1p36 deletion
4p deletion
Others
Roberts syndrome
Cornelia de Lange syndrome
Sotos syndrome
Multiple pterygium
Ultrasound Evaluation of Fetal Lymphangiomas 3
+MODEL
Please cite this article in press as: Chen Y-N, et al., Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas
and Lymphangiomas, Journal of Medical Ultrasound (2017), http://dx.doi.org/10.1016/j.jmu.2017.02.001
problems. MRI can be used to assess the size and infiltration
of cystic hygroma.
Several studies have suggested that patients with fetal
cystic hygroma and hydrops fetalis without chromosome
abnormalities or other structural abnormalities are candi-
dates for intrauterine sclerotherapy [21e23]. Mikovic et al
[23] reported two patients with fetal neck lymphangiomas
with intrauterine injection of OK-432 at 28 weeks of
gestational age. Aspiration of fluid in cystic hygroma and
injection of same volume of OK-432 were performed.
Increased echogenicity of the cysts was noted after injec-
tion. After the regular follow-up, both the patients were
born without the obvious neck mass and good outcome.
Direct OK-432 injection of the lymphangioma is widely used
in patients with lymphangioma postnatally. However, the
case numbers are sparse in intrauterine injection, and more
case studies are warranted.
After thorough assessment of fetal anatomy, for those
with the risk of airway obstruction at delivery, ex utero
intrapartum treatment is the gold standard strategy. It can
protect the fetuses from neonatal hypoxia and brain injury.
It should be performed under the supervision of a multi-
disciplinary team of obstetricians, anesthesiologists, pedi-
atric surgeons, neonatologists, otolaryngologists, and a
group of operating room nurses and personnel. Therefore,
prenatal counseling is crucial.
Postnatal management includes surgical excision, direct
injection of sclerosing agents, and oral sirolimus. Surgical
excision is one of the treatments, especially for localized
lymphangioma, but local recurrence has been reported after
surgery [24]. Injection of sclerosing agents, such as Bleo-
mycin or OK-432, directly into the mass has been applied for
decreasing the mass size or for total resolution. Oral siroli-
mus was used after birth with decreasing size of axillary
lymphangioma, but the outcome should be followed [25].
Although cystic hygromas or lymphangiomas are common
fetal anomalies during pregnancy and often associated with
poor outcome, in some cases, appropriate counseling and
prenatal evaluation can result in better outcome for the
fetuses.
References
[1] Wassef M, Blei F, Adams D, et al. Vascular anomalies classifi-
cation: recommendations from the International Society for
the Study of Vascular Anomalies. Pediatrics 2015;136:
e203e14.
[2] Giacalone PL, Boulot P, Deschamps F, et al. Prenatal diagnosis
of cavernous lymphangioma of the arm. Ultrasound Obstet
Gynecol 1993;3:48e50.
[3] Schild RL, Orhan Y, Meyberg H, et al. Three-dimensional ul-
trasound of a massive fetal lymphangioma involving the lower
extremity. Ultrasound Obstet Gynecol 2003;22:547e9.
[4] Chen CP, Liu FF, Jan SW, et al. Cytogenetic evaluation of cystic
hygroma associated with hydrops fetalis, oligohydramnios or
intrauterine fetal death: the roles of amniocentesis, postmor-
tem chorionic villus sampling and cystic hygroma paracentesis.
Acta Obstet Gynecol Scand 1996;75:454e8.
[5] Rosati P, Guariglia L. Prognostic value of ultrasound findings of
fetal cystichygroma detected in earlypregnancy by transvaginal
sonography. Ultrasound Obstet Gynecol 2000;16:245e50.
[6] Phillips HE, McGahan JP. Intrauterine fetal cystic hygromas:
sonographic detection. AJR Am J Roentgenol 1981;136:
799e802.
[7] Ville Y, Lalondrelle C, Doumerc S, et al. First-trimester diag-
nosis of nuchal anomalies: significance and fetal outcome.
Ultrasound Obstet Gynecol 1992;2:314e6.
[8] Furue A, Mochizuki J, Onishi Y, et al. Ultrasonic findings of
fetal axillary lymphangioma with intralesional hemorrhage. J
Med Ultrason 2001;2016(43):285e9.
[9] Malone FD, Ball RH, Nyberg DA, et al. First-trimester septated
cystic hygroma: prevalence, natural history, and pediatric
outcome. Obstet Gynecol 2005;106:288e94.
[10] Sanhal CY, Mendilcioglu I, Ozekinci M, et al. Prenatal man-
agement, pregnancy and pediatric outcomes in fetuses with
septated cystic hygroma. Braz J Med Biol Res 2014;47:
799e803.
[11] Graesslin O, Derniaux E, Alanio E, et al. Characteristics and
outcome of fetal cystic hygroma diagnosed in the first
trimester. Acta Obstet Gynecol Scand 2007;86:1442e6.
[12] Tanriverdi HA, Ertan AK, Hendrik HJ, et al. Outcome of cystic
hygroma in fetuses with normal karyotypes depends on asso-
ciated findings. Eur J Obstet Gynecol Reprod Biol 2005;118:
40e6.
[13] Ganapathy R, Guven M, Sethna F, et al. Natural history and
outcome of prenatally diagnosed cystic hygroma. Prenat Diagn
2004;24:965e8.
[14] Grande M, Jansen FA, Blumenfeld YJ, et al. Genomic micro-
array in fetuses with increased nuchal translucency and
normal karyotype: a systematic review and meta-analysis.
Ultrasound Obstet Gynecol 2015;46:650e8.
[15] Pan M, Han J, Zhen L, et al. Prenatal diagnosis of fetuses with
increased nuchal translucency using an approach based on
quantitative fluorescent polymerase chain reaction and
genomic microarray. Eur J Obstet Gynecol Reprod Biol 2016;
197:164e7.
[16] Brumfield CG, Wenstrom KD, Davis RO, et al. Second-trimester
cystic hygroma: prognosis of septated and nonseptated le-
sions. Obstet Gynecol 1996;88:979e82.
[17] Scholl J, Durfee SM, Russell MA, et al. First-trimester cystic
hygroma: relationship of nuchal translucency thickness and
outcomes. Obstet Gynecol 2012;120:551e9.
[18] Noia G, Pellegrino M, Masini L, et al. Fetal cystic hygroma: the
importance of natural history. Eur J Obstet Gynecol Reprod
Biol 2013;170:407e13.
[19] Masood SN, Masood MF. Case report of fetal axillo-thoraco-
abdominal cystic hygroma. Arch Gynecol Obstet 2010;281:
111e5.
[20] Mondal PC, Ghosh D, Mondal A, et al. Congenital fetal lym-
phangioma causing shoulder dystocia and uterine rupture. Int
J Gynaecol Obstet 2011;112:248.
[21] Ogita K, Suita S, Taguchi T, et al. Outcome of fetal cystic
hygroma and experience of intrauterine treatment. Fetal
Diagn Ther 2001;16:105e10.
[22] Sasaki Y, Chiba Y. Successful intrauterine treatment of cystic
hygroma colli using OK-432. A case report. Fetal Diagn Ther
2003;18:391e6.
[23] Mikovic Z, Simic R, Egic A, et al. Intrauterine treatment of
large fetal neck lymphangioma with OK-432. Fetal Diagn Ther
2009;26:102e6.
[24] Surico D, Amadori R, D’Ajello P, et al. Antenatal diagnosis of
fetal lymphangioma by ultrasonography. Eur J Obstet Gynecol
Reprod Biol 2013;168:236.
[25] Ersoy AO, Oztas E, Saridogan E, et al. An unusual origin of fetal
lymphangioma filling right axilla. J Clin Diagn Res 2016;10:
QD09e11.
4 Y.-N. Chen et al.
+MODEL
Please cite this article in press as: Chen Y-N, et al., Prenatal Ultrasound Evaluation and Outcome of Pregnancy with Fetal Cystic Hygromas
and Lymphangiomas, Journal of Medical Ultrasound (2017), http://dx.doi.org/10.1016/j.jmu.2017.02.001
... Diagnosing these lesions may be very challenging in small biopsies given their cystic nature and bland cytologic features. In higher-resourced settings like the United States, one could expect to detect a cystic hygroma early in pregnancy during routine prenatal ultrasound or during a third trimester anatomy scan [4][5][6][7][8]. In contrast, ultrasound is conducted far less frequently in our setting in Tanzania, with approaches varying by provider and practice setting due to resource constraints. ...
... This revealed a large mass in the anterior triangle of the fetal neck. The leading diagnosis was CH due to increased nuchal thickness (≥3 mm), the complex cystic nature, and the location of the mass [ 4]. While we did not detect other anomalies in this case, the most commonly associated findings on ultrasound are hydrops fetalis, cardiac malformations, and skeletal abnormalities, regardless of normal versus abnormal karyotype [ 4]. ...
... The leading diagnosis was CH due to increased nuchal thickness (≥3 mm), the complex cystic nature, and the location of the mass [ 4]. While we did not detect other anomalies in this case, the most commonly associated findings on ultrasound are hydrops fetalis, cardiac malformations, and skeletal abnormalities, regardless of normal versus abnormal karyotype [ 4]. Advanced imaging techniques such as CT and MRI were not feasible. ...
Article
Full-text available
Introduction and importance: Cystic hygroma is a benign congenital malformation of lymphatic and blood vessels, with an incidence of 1 in 6000 live births. Most cases are associated with genetic syndromes and can compromise fetal viability. Due to its rarity, comprehensive data is limited, mainly relying on case reports. Case presentation: A 21-year-old pregnant woman at 27 weeks' gestation presented to triage with abdominal pain. Abdominal ultrasound revealed a single living female fetus with an estimated fetal weight of 734 g and a complex cystic mass causing hyper-extension of the neck. The pregnancy was terminated given the poor prognosis. Histopathology of the mass confirmed it to be a cystic hygroma. Clinical discussion: In limited-resource settings, management of huge cystic hygromas often necessitates termination of pregnancy due to a lack of sufficient resources for complex interdisciplinary interventions for the mother and infant after birth. In such cases, focus should be shifted toward promoting shared decision-making and sensitive patient counseling. Conclusion: Cystic hygromas that are diagnosed prenatally generally have a poorer prognosis than those diagnosed after birth. The management of cystic hygramas, particularly those diagnosed prenatally, represents a persistent challenge in low-resourced settings. Counseling and treatment recommendations must be tailored based on tumor characteristics, the expected prognosis, and the feasibility of medical or surgical intervention in a given clinical environment.
... The color Doppler does not show any blood flow within the cyst. It is essential to correctly identify cystic hygromas and look for associated findings such as hydrops fetalis, cardiac malformations, and skeletal abnormalities [6]. Cystic hygromas are frequently diagnosed in the first trimester and affect about one in every 285 pregnancies. ...
Article
Full-text available
Cystic hygromas detected prenatally usually have a poor prognosis; hence, a correct and early diagnosis is essential. A prenatal ultrasound may detect a cystic hygroma as early as 10 weeks of gestation. Knowledge of the imaging findings and prognostic factors is necessary for effective perinatal counseling. Nuchal cystic hygromas (NCHs) in fetuses present a rare and challenging medical situation for prenatal care providers. This case report aims to describe a particular case of NCH detected through routine prenatal ultrasound, emphasizing the diagnostic demanding situations, management decisions, and final results. The etiology of NCHs remains multifactorial and complicated. Despite the fact that a few instances are sporadic, a great proportion has been associated with genetic aberrations, mainly chromosomal anomalies such as Turner syndrome, trisomy 21, and trisomy 18. Recent advances in molecular genetic testing, together with chromosomal microarray analysis and non-invasive prenatal testing, have facilitated the identification of the underlying genetic factors, contributing to a better knowledge of the pathogenesis of NCHs. In fetuses, they pose a complex scientific state of affairs with diverse implications. Advances in diagnostic techniques and genetic testing have notably progressed our capacity to become aware of related anomalies, offering precious insights into diagnosis and management alternatives. However, further research is warranted to get to the bottom of the underlying mechanisms of NCH development, enhance prenatal counseling, and refine therapeutic procedures to optimize outcomes for affected pregnancies.
... lymphangioma, which is a vascular anomaly caused by uid accumulation in the cervicofacial and axillary regions. Cystic hygroma is most often located in the neck (75%), followed by the axilla (20%), retroperitoneum and intra-abdominal organs [12] (2%), limbs and bones (2%), and mediastinum (1%) . They may appear as a nuchal cyst on prenatal ultrasonography and may include septations +/-signs of fetal anasarca/ hydrops fetalis. ...
Article
In today's obstetrics, the ultrasound is one of the most often utilized diagnostic tools for identifying fetal developmental abnormalities. However, it is crucial to understand which defects may be diagnosed with great certainty during pregnancy and which ones can only be discovered partially or not at all before giving birth. Our study aims to evaluate the role of ultrasound in detecting congenital fetal anomalies and to nd out the most common system involved / most common fetal anomaly encountered in our institution. Prenatal diagnostics also requires a great deal of medical professional responsibility because the effects of an unintentionally incorrect diagnosis can have a negative impact on both the fetus and the family.
... Lymphatic malformations are rare with an occurrence is 1 in 6,000 live births. [1] Half of these lesions are typically present at birth. [2] They are classified as microcystic, macrocystic, and mixed based on the size of the cyst (cut off 2cm). ...
... According to a survey conducted by Chen et al., cystic hygroma has a poor outcome because it is usually associated with hydrops fetalis and chromosomal abnormalities, especially in fetuses with other major malformations [37]. Here a rare case of a fetus with cystic hygroma accompanied with multiple anomalies is shown (Figure 4). ...
Article
Full-text available
Background: This study was aimed to evaluate the characteristics and outcomes of isolated CHD and non-isolated CHD and also compare with major and minor cardiac anomalies.
Article
Nuchal translucency (NT) is the ultrasound observation of subcutaneous fluid accumulation at the back of the fetal neck, which, when excessively enlarged, can lead to nuchal edema or cystic hygroma. Elevated NT is associated with chromosomal anomalies and pregnancy complications. Cystic hygroma (CH) is caused by lymphatic system blockage, resulting in fluid-filled pseudocysts. Its incidence varies, but it is usually rare in the general population. CH is commonly detected during prenatal screenings, with higher incidences in populations undergoing extensive testing. It can be associated with genetic conditions like Turner and Down syndromes, influenced by geographic regions and maternal age. Ultrasound is an established method for CH diagnosis, revealing multiseptated cystic masses. A normal karyotype is found in only 20-50% of cases. The management varies from expectant monitoring to pregnancy termination, depending on severity and associated anomalies. The risk of recurrence depends on karyotype; normal karyotypes have a higher recurrence risk. Spontaneous resolution of cystic hygroma has been reported in some cases. To illustrate this situation, we present the case of a patient with a spontaneously regressed CH associated with a normal karyotype and a favorable outcome. In conclusion, cystic hygroma management and counseling should consider the presence of chromosomal abnormalities, but recent studies reveal a more optimistic perspective once these abnormalities are ruled out. Collaborative counseling is essential for informed decision-making during pregnancy regarding fetal interventions, neonatal care or palliative care.
Article
Congenital neck masses are rare lesions typically encountered during second-trimester anatomy ultrasound. Accurate diagnosis is crucial to appropriate ante- and perinatal management though imaging characterization remains a challenge. Ultrasound and MRI play complementary roles in the diagnosis of prenatal head and neck masses now facilitated by the increased availability of fetal MRI, technologic advancements in both imaging modalities and large tertiary referral centers with specialized care teams. As in both adult and pediatric head and neck imaging, a solid understanding of the neck anatomic spaces is a requisite to formulate a focused differential diagnosis. In this review, the more common fetal neck masses in four anatomic locations are presented. Unlike the wide spectrum of potential pathologies encountered in children, fetal neck masses can be categorized into three major groups: tumors, vascular malformations, and congenital lesions. Using an anatomic and systematic approach, the radiologist can narrow the differential diagnosis into a single or a limited list of possibilities. This article provides a focused review of the more common fetal head and neck pathologies, emphasizing their location and imaging characteristics. Based on these features, a reasonable differential diagnosis can be formulated and applied to prenatal counseling, delivery management, and postnatal treatment.
Chapter
A cystic hygroma is defined as “sequestration of some lymphatics and loss of communication with the main trunk.” It is a benign malformation of the lymphatic system that can arise anywhere in the body but is classically found in the posterior triangle of the neck and axilla. Most cystic hygromas (50–65%) are evident at birth, and 80–90% are present by the age of 2 years. The usual presentation apparent at birth is a large, diffuse, painless mass, which varies in size from few centimeters to a huge lump filling the whole side of the neck, causing respiratory distress and feeding difficulty. A cyst in the posterior triangle may deeply extend beneath the sternocleidomastoid muscle into the retropharyngeal space. It may be unilateral or bilateral. The prenatal diagnosis of a cystic hygroma using ultrasound is well-documented in the literature. The most preferred modality of treatment is complete surgical excision; however, remarkable results with sclerosants have been reported. Other treatment modalities include simple drainage, aspirations, radiation, laser excision, radio-frequency ablation (RFA), and cauterization. Treatment options should be individualized depending on the size, anatomical location, and complications of the lesion. In general, morbidity of a cystic hygroma is related to cosmetic disfigurement and impingement on critical cervical structures, such as the nerves, vessels, and the laryngotracheal complex. This chapter discusses the terminology, embryology, epidemiology, clinical presentation, classification, staging, pre- and postnatal evaluation, differential diagnosis, treatment modalities, and prognosis of cystic hygromas.KeywordsLateral neckCystic swellingCystic hygromaLymphangiomaSurgical excisionDrainageAspirationRadiationLaser excisionRadio-frequency ablationCauterization
Article
Full-text available
It has been reported that, compared with simple increased nuchal translucency, fetal cases with septated cystic hygroma (CH) are more likely to face perinatal handicaps. However, pediatric outcomes and proper prenatal counseling for this anomaly have not yet been truly defined. We performed this study to determine pregnancy and pediatric outcomes of fetuses with septated CH. We searched records for cases with septated CH and collected data for structural abnormalities, karyotype analysis, and pregnancy outcomes. Fetuses born with septated CH were also evaluated for their pediatric outcomes. Sixty-nine fetuses with septated CH were enrolled in the study. Results showed that chromosomal abnormalities were present in 28 fetuses (40.6%), and the most common aneuploidy was Turner syndrome (n=14, 20.3%); 16 (23.2%) of the remaining cases, in which aneuploidy was not found, had coexistent structural malformations; 25 (36.2%) cases had normal karyotype and morphology. The total number of live births and infants with unfavorable neurologic follow-up were 13 (18.8%) and 2 (2.9%), respectively. Septated CH is associated with poor perinatal outcomes; therefore, karyotype analysis and ultrasonographic anomaly screening should be performed as initial steps, and expectant management should be offered to couples with euploid fetuses that have normal morphology.
Article
Full-text available
Fetal lymphangioma is a hamartomatous congenital anomaly of the lymphatic system, which is embracing the fetal skin (sometimes mucous membranes) and the subcutaneous tissue. The general consensus is that it occurs as a result of failure in lymphatic drainage. A 36-year-old pregnant woman was referred to our perinatology clinic at 22 weeks’ gestation, because of a fetal right-sided axillary mass revealed by ultrasonography. The mass measuring 5x7x7cm in three dimensions had a multilocular structure without colour Doppler flow and well-circumscribed borders. Amniocentesis revealed a normal constitutional karyotyping. Lymphangioma was considered as prediagnosis. A healthy female baby weighing 3470 grams was delivered at term. Neonatal examination and the postnatal MRI confirmed the diagnosis. The baby is still on follow-up with the medical treatment of Sirolimus an anti-proliferative drug, and the mass got smaller significantly in 8 months after delivery.
Article
Full-text available
Vascular anomalies represent a spectrum of disorders from a simple "birthmark" to life- threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced by patients with these anomalies. Accurate diagnosis is crucial for appropriate evaluation and management, often requiring multidisciplinary specialists. Classification schemes provide a consistent terminology and serve as a guide for pathologists, clinicians, and researchers. One of the goals of the International Society for the Study of Vascular Anomalies (ISSVA) is to achieve a uniform classification. The last classification (1997) stratified vascular lesions into vascular malformations and proliferative vascular lesions (tumors). However, additional disease entities have since been identified that are complex and less easily classified by generic headings, such as capillary malformation, venous malformation, lymphatic malformation, etc. We hereby present the updated official ISSVA classification of vascular anomalies. The general biological scheme of the classification is retained. The section on tumors has been expanded and lists the main recognized vascular tumors, classified as benign, locally aggressive or borderline, and malignant. A list of well-defined diseases is included under each generic heading in the "Simple Vascular Malformations" section. A short definition is added for eponyms. Two new sections were created: one dealing with the malformations of individually named vessels (previously referred to as "truncular" malformations); the second groups lesions of uncertain or debated nature (tumor versus malformation). The known genetic defects underlying vascular anomalies are included in an appendix. This classification is meant to be a framework, acknowledging that it will require modification as new scientific information becomes available. Copyright © 2015 by the American Academy of Pediatrics.
Article
Full-text available
It has been reported that, compared with simple increased nuchal translucency, fetal cases with septated cystic hygroma (CH) are more likely to face perinatal handicaps. However, pediatric outcomes and proper prenatal counseling for this anomaly have not yet been truly defined. We performed this study to determine pregnancy and pediatric outcomes of fetuses with septated CH. We searched records for cases with septated CH and collected data for structural abnormalities, karyotype analysis, and pregnancy outcomes. Fetuses born with septated CH were also evaluated for their pediatric outcomes. Sixty-nine fetuses with septated CH were enrolled in the study. Results showed that chromosomal abnormalities were present in 28 fetuses (40.6%), and the most common aneuploidy was Turner syndrome (n=14, 20.3%); 16 (23.2%) of the remaining cases, in which aneuploidy was not found, had coexistent structural malformations; 25 (36.2%) cases had normal karyotype and morphology. The total number of live births and infants with unfavorable neurologic follow-up were 13 (18.8%) and 2 (2.9%), respectively. Septated CH is associated with poor perinatal outcomes; therefore, karyotype analysis and ultrasonographic anomaly screening should be performed as initial steps, and expectant management should be offered to couples with euploid fetuses that have normal morphology.
Article
Objective: To assess the clinical value of prenatal diagnosis of fetuses with increased nuchal translucency (NT) using an approach based on quantitative fluorescent polymerase chain reaction (QF-PCR) and chromosomal microarray (CMA). Study design: From January 2013 to October 2014, we included 175 pregnancies with fetal NT ≥3.5mm at 11-13 weeks' gestation who received chorionic villus sampling. QF-PCR was first used to rapidly detect common aneuploidies. The cases with a normal QF-PCR result were analyzed by CMA. Results: Of the 175 cases, common aneuploidies were detected by QF-PCR in 53 (30.2%) cases (30 cases of trisomy 21, 12 cases of monosomy X, 7 cases of trisomy 18, 3 cases of trisomy 13 and 1 case of 47, XXY). Among the 122 cases with a normal QF-PCR result, microarray detected additional pathogenic copy number variants (CNVs) in 5.7% (7/122) of cases. Four cases would have expected to be detectable by conventional karyotyping because of large deletions/duplications (>10Mb), leaving three cases (2.5%; 3/118) with pathogenic CNVs only detectable by CMA. Conclusion: It is rational to use a diagnostic strategy in which CMA is preceded by the less expensive, rapid, QF-PCR to detect common aneuploidies. CMA allows detection of a number of pathogenic chromosomal aberrations in fetuses with a high NT.
Article
We report a case of an axillary lymphangioma in a fetus delivered at 30 weeks' gestation with suspected intralesional hemorrhage based on the ultrasonic findings. In the ultrasonic examination at 15 weeks' gestation, the fetus was found to have a multilocular mass spreading from the axilla to the chest wall, which was diagnosed as an axillary lymphangioma. Chromosome analysis by amniocentesis showed a normal karyotype, and no other malformations were observed. At 29 weeks, the mass had increased in size, and color Doppler ultrasound examination revealed that the middle cerebral artery peak systolic velocity (MCA-PSV) reached 80.2 cm/s [1.86 MoM (multiples of the median)]. Intralesional bleeding was suspected because of the multiple images of hemorrhage in which sites of blood spouting in a pulsatile fashion were detected within the mass. Cordocentesis at 30 weeks revealed that fetal hemoglobin concentration was 5.1 g/dL. An emergency Cesarean section was performed. A female weighing 2810 g, including the mass, was delivered, and the blood hemoglobin level was 5.9 g/dL at birth. Blood transfusion, fine-needle aspiration of the fluid in the mass, intralesional injection of OK-432, and partial excision of the lymphangioma were performed after birth. Ultrasonic examination proved useful in the diagnosis of intralesional bleeding in this lymphangioma.
Article
To perform a systematic review of the literature and meta-analysis and estimate the incremental yield of genomic microarray over karyotyping in fetuses with increased nuchal translucency (NT) diagnosed by first trimester prenatal ultrasound. All articles identified in PubMed, Ovid Medline and Web of Science, from January 2009 to September 2014 describing copy number variants (CNVs) in fetuses with increased NT, usually defined as ≥ 3.5 mm, and normal karyotype, were included. Search terms were: fetal or prenatal, nuchal translucency or cystic hygroma or ultrasound anomaly, array comparative genomic hybridization or copy number variants, with related search terms. Risk differences were pooled to estimate the overall and stratified microarray incremental yield using RevMan. Quality assessment of included studies was performed using the Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS-2) checklist. Seventeen publications met the inclusion criteria for the analysis. A 5% (95% CI 2.0-8.0) incremental yield by microarray was obtained pooling the results. Stratified analysis demonstrated a 4% (95% CI 2.0-7.0) incremental yield for isolated NT and 7% (95% CI 2.0-12) when other malformations are present. The most common pathogenic CNV reported were 22q11.2 deletion, 22q11.2 duplication, 10q26.12q26.3 deletion and 12q21q22 deletion. The pooled prevalence for variants of uncertain significance (VOUS) was 1%. The review found that the use of genomic microarray provides a 5% incremental yield in fetuses with increased NT and normal karyotype. This article is protected by copyright. All rights reserved.
Article
To evaluate the natural history of cystic hygroma (CH) in fetal and neonatal periods to enrich parental counselling. Ultrasonographic characteristics, associated syndromes, chromosomal anomalies, fetal cardiac pathology and life after birth were considered. From May 1985 to September 2010, 207 pregnancies were seen the authors' centre with suspected vascular-lymphatic fetal malformation: 156 of them had CH. Cases were followed up by telephone interview to determine fetal and neonatal outcomes. Chi-squared test was used for statistical analysis. Among the 156 cases of CH, the condition was septated in 75% of cases, associated with other pathologies in 74%, and retronuchal in 88%. Intrauterine regression was seen in 36% of cases, with complete disappearance in 77%. The karyotype was normal in 55% of cases. Follow-up was completed in 85 cases and revealed 54 spontaneous abortions (63%) and 31 live births (37%). Amongst these, 21 out of 31 children had a favourable outcome (68%). A negative embryo-fetal outcome was significantly associated with CH being associated with other pathologies, such as hydrops, retronuchal position and altered karyotype. Spontaneous regression or resolution of CH was associated with live births. The management of pregnancies with a diagnosis of fetal CH requires knowledge of natural history of the malformation for appropriate parental counselling.